The Validity of Health-Related Quality of Life Instruments in Patients With Late-Stage Parkinson’s Disease

por Ramadhan, Mouhammed, Schrag, Anette
Publicado 2022

Disorders of the Basal Ganglia and Their Modern Management

por Schrag, Anette, Quinn, Niall
Publicado 1999

Caregiver Burden and Quality of Life in Late Stage Parkinson’s Disease

por Rosqvist, Kristina, Schrag, Anette, Odin, Per
Publicado 2022

Support Needs in Carers of People With Parkinson’s From Early to Later Stages: A Qualitative Study With 36 Carers in 11 European Countries

por Merritt, Rowena K., Hotham, Sarah, Schrag, Anette
Publicado 2023

The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease

por Charidimou, Andreas, Seamons, John, Selai, Caroline, Schrag, Anette
Publicado 2011

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?

por Weil, Rimona S., Costantini, Alyssa A., Schrag, Anette E.
Publicado 2018

The prodromes of Parkinson's disease

por Rees, Richard Nathaniel, Noyce, Alastair John, Schrag, Anette
Publicado 2018

Change in the incidence of Parkinson’s disease in a large UK primary care database

por Okunoye, Olaitan, Marston, Louise, Walters, Kate, Schrag, Anette
Publicado 2022

Imaging Psychogenic Movement Disorders

por Mehta, Arpan R., Rowe, James B., Schrag, Anette E.
Publicado 2013

The prediagnostic phase of Parkinson's disease

por Noyce, Alastair John, Lees, Andrew John, Schrag, Anette-Eleonore
Publicado 2016

Why do patients with Parkinson’s disease fall? A cross-sectional analysis of possible causes of falls

por Schrag, Anette, Choudhury, Mahbuba, Kaski, Diego, Gallagher, David A
Publicado 2015

Measures of fidelity of delivery and engagement in self-management interventions: A systematic review of measures

por Rookes, Tasmin A, Schrag, Anette, Walters, Kate, Armstrong, Megan
Publicado 2022

The experience of Anxiety for people with Parkinson’s disease

por Blundell, Emma. K., Grover, Laura. E., Stott, Joshua, Schrag, Anette
Publicado 2023

Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson’s disease

por Costello, Harry, Schrag, Anette-Eleonore, Howard, Robert, Roiser, Jonathan P.
Publicado 2023

Validation of a comorbidity questionnaire in patients with neurological disorders

por Vijiaratnam, Nirosen, Vadera, Shree, Lefringhausen, Katharina, Girges, Christine, Schrag, Anette
Publicado 2023

Adolescent and Adult Children of Parents with Parkinson's Disease: Incorporating Their Needs in Clinical Guidelines

por Morley, David, Selai, Caroline, Schrag, Anette, Jahanshahi, Marjan, Thompson, Alan
Publicado 2011

Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations

por Schrag, Anette, Anastasiou, Zacharias, Ambler, Gareth, Noyce, Alastair, Walters, Kate
Publicado 2019

Rate of hospitalizations and underlying reasons among people with Parkinson’s disease– Population-based cohort study in UK primary care

por Okunoye, Olaitan, Horsfall, Laura, Marston, Louise, Walters, Kate, Schrag, Anette
Publicado 2022

Mortality of People with Parkinson’s Disease in a Large UK-Based Cohort Study: Time Trends and Relationship to Disease Duration

por Okunoye, Olaitan, Horsfall, Laura, Marston, Louise, Walters, Kate, Schrag, Anette
Publicado 2021

Orthostatic Hypotension and Antiparkinsonian Drugs: A Systematic Review and Meta-analysis

por Nimmons, Danielle, Bhanu, Cini, Orlu, Mine, Schrag, Anette, Walters, Kate
Publicado 2021